© RETONH& Co., Ltd. All rights Reserved.
With the vision of 'restoring patients to a healthy state through innovative research', we are leading the way in improving healthcare quality with innovative products across pharmaceuticals, medical devices, and health functional foods that promote healthy living for humanity.
The corporate research center at RETONH& was established in 2023 with the goal of advancing research and development in the medical device field and fostering talented professionals. Starting with the development of REOGEN (a second-class medical device adhesive transparent wound dressing) in 2024, the center is evolving into a specialized research hub. We engage in both long-term and short-term research planning, conduct fundamental research and technical studies for new product development, and pursue product improvement research. Additionally, we collaborate on joint research and development projects with industries, universities, and research institutions. Through diverse studies in pharmaceuticals, medical devices, and health functional foods under our core brand, REOLAB, the research center plays a central role in our strategic healthcare business.
Regenerative Medicine
Research on Natural Materials
Research on Biomaterials for Medical Use
AMC Techonology is a proprietary technology of RETONH& Co., Ltd., representing a natural medical substance with outstanding bioactivity. It is applied in pharmaceuticals and medical devices, providing antibacterial, antifungal, antioxidant, and cell-regeneration functionalities.
A technology that optimizes the molecular weight of chitosan to enhance bioactivity and enable its application across various products.
A high-efficiency technology for separating and purifying AMC at optimal molecular weights for use as a medical raw material.
